Trade Summary

3 days ago, Tanguler Tolga, serving as EVP, Chief Commercial Officer at Alnylam Pharmaceuticals, Inc. (ALNY), sold 1,598 shares at $327.65 per share, for a total transaction value of $523,584.00. Following this transaction, Tanguler Tolga now holds 36,606 shares of ALNY.

This sale represents a 4.00% decrease in Tanguler Tolga's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 2 days after the trade was made.

Alnylam Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.